Theravectys

Gene Therapy Delivery Methods

This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.

VIVEbiotech

VIVEbiotech manufactures lentiviral vectors for pharmaceutical and biotechnology companies developing gene and cell therapies.

Themis Bioscience

This biotechnology company develops vaccines and immune-modulation therapies for infectious diseases and cancer to protect human populations from unmet medical needs.

Dispatch Biotherapeutics

This biotechnology company develops precision-targeted immunotherapies and viral vector platforms to treat patients with various solid tumour cancers.

Fuse Vectors

This company develops a cell-free enzymatic platform to manufacture viral vectors for pharmaceutical and biotechnology clients to produce gene therapies.

Vectiopep

This company develops peptide-based nucleic acid delivery technology for biotechnology firms and researchers to create targeted messenger RNA cancer immunotherapies.

Salve Therapeutics

The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.

Lentitek

This company develops manufacturing technologies for lentiviral vectors to help cell and gene therapy developers improve the production of advanced cancer treatments.